KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 154 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $7,568,000 | -22.3% | 1,291,531 | +68.7% | 0.31% | -1.6% |
Q1 2015 | $9,744,000 | -41.8% | 765,450 | -35.3% | 0.32% | -47.5% |
Q4 2014 | $16,746,000 | -37.0% | 1,183,484 | -38.8% | 0.60% | -37.9% |
Q3 2014 | $26,585,000 | -55.5% | 1,933,484 | -50.2% | 0.97% | -59.7% |
Q2 2014 | $59,742,000 | +149.9% | 3,884,409 | +176.8% | 2.40% | +146.1% |
Q1 2014 | $23,909,000 | +24.5% | 1,403,105 | -5.4% | 0.98% | -1.9% |
Q4 2013 | $19,208,000 | -50.5% | 1,483,260 | -61.5% | 1.00% | -44.9% |
Q3 2013 | $38,839,000 | -11.3% | 3,849,296 | -34.4% | 1.81% | -12.5% |
Q2 2013 | $43,809,000 | – | 5,864,612 | – | 2.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 1,605,800 | $16,026,000 | 4.65% |
Baupost Group | 25,791,678 | $257,401,000 | 4.29% |
1492 Capital Management LLC | 264,297 | $2,638,000 | 1.67% |
Cormorant Asset Management, LP | 826,000 | $8,243,000 | 1.10% |
FALCON POINT CAPITAL, LLC | 251,137 | $2,506,000 | 0.85% |
OAK RIDGE INVESTMENTS LLC | 3,291,711 | $32,851,000 | 0.70% |
Knoll Capital Management, LLC | 200,000 | $1,996,000 | 0.64% |
Rhenman & Partners Asset Management AB | 534,000 | $5,329,000 | 0.64% |
Old West Investment Management, LLC | 79,667 | $795,000 | 0.55% |
THREE BAYS CAPITAL LP | 1,284,000 | $12,814,000 | 0.53% |